Aerpio Obtains $27M In Series A To Fund Pair Of Phase II Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
The recently spun-out company raised money to fund two Phase II trials in hopes of garnering a partner for its diabetic macular edema drug.